Novo Nordisk CEO's pay sets itself apart on especially one point

German investment bank Berenberg has compared the salaries of a range of top execs in the pharmaceutical industry, and in opposition to everyone else, Lars Fruergaard Jørgensen's bonus scheme is not tied to the company share price.
Novo Nordisk President & CEO | Photo: Stine Bidstrup/ERH
Novo Nordisk President & CEO | Photo: Stine Bidstrup/ERH
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY NIELSINE NIELSEN

The bonus scheme of Novo Nordisk CEO and President Lars Fruergaard Jørgensen is not tied in with the share price of the Danish pharmaceutical company, which comes as a surprise to German investment bank Berenberg.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading